Journal of Case Reports in Practice
Volume:7 Issue: 2, Apr 2019

Acetaminophen (paracetamol) is a commonly used safe drug for reducing pain and fever in children. The drug is available in many forms, and its parenteral form has become approved by food and drug association (FDA) in 2010 and then more than 80 countries in all over the world use this form widely. More side effects are rash and drug allergy, diarrhea, abdominal pain and its less common side effects are nephrotoxicity and oliguria, pancytopenia and liver involvement. However, cardiovascular and respiratory complications have also been mentioned with the intravenous form of the drug, which include hypoxia, eosinophilic pneumonitis, and hypotention. This report is a rare pulmonary complications of acetaminophen in infant with usual dosage of intravenous form.

Immune thrombocytopenic purpura (ITP) is a disease characterized by low platelet count (<150,000/mm3). The suitable treatment for newly diagnosed ITP recommend longer courses of corticosteroids (eg, prednisone 1 mg/kg orally for 21 days then tapered off) or IVIg because longer courses of corticosteroids are associated with a longer time to the loss of response. We know that corticosteroids may cause side effects such as cataract, increased intraocular pressure and rarely central serous chorioretinopathy. This case report presents a patient with central serous chorioretinopathy after treatment for Immune thrombocytopenic purpura (ITP) that his visual outcome didn’t appropriate responses to our conventional therapy (corticosteroids stop). So we emphasize the thrombocytopenia could be the most responsible for CSCR in immune thrombocytopenic purpura patients.